Phase
Condition
Endometrial Cancer
Treatment
carboplatin
SSGJ-707
paclitaxel
Clinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age:18-75 years old
Advanced endometrial cancer and platinum-resistant ovarian cancer
Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.
Expected survival >=12 weeks.
Signed informed consent form.
Exclusion
Exclusion Criteria:
Known uncontrolled or symptomatic central nervous system metastatic disease.
Adverse events (with exception of alopecia and fatigue) from any prior anticancertherapy of grade >1 (National Cancer Institute Common terminology Criteria [NCICTCAE] v.5.0).
Inadequate organ or bone marrow function.
Pregnant or breast-feeding woman.
Known allergies, hypersensitivity, or intolerance to SSGJ-707 The above informationwas not intended to contain all considerations relevant to a participant's potentialparticipation in a clinical trial.
Study Design
Connect with a study center
Zhou Qi
Chongqing, Chongqing
ChinaSite Not Available
Chongqing Cancer Hospital
Chongqing,
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.